Finance

Lists
MNPR:NASDAQ
Monopar Therapeutics Inc
72,00 $
-0,94%
(-0,68) 1D
13 նոյ, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MNPR...
Open
72,93 $
High
73,67 $
Low
67,70 $
Mkt. cap
483,28 մլն
Avg. vol.
150,77 հզր
Volume
203,86 հզր
52-wk high
124,42 $
52-wk low
50,07 $
EPS
-2,17 $
Beta
1,62
Shares outstanding
6,71 մլն
No. of employees
22
Open
72,93 $
High
73,67 $
Low
67,70 $
Mkt. cap
483,28 մլն
Avg. vol.
150,77 հզր
Volume
203,86 հզր
52-wk high
124,42 $
52-wk low
50,07 $
EPS
-2,17 $
Beta
1,62
Shares outstanding
6,71 մլն
No. of employees
22
News stories
From web sources and news partners
About Monopar Therapeutics Inc
CEO-
Employees22
Founded2014
HeadquartersՈւիլմետ, Իլինոյս, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websitemonopartx.com
Analyst ratings
Based on 6 analysts giving stock ratings to MNPR in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for MNPR in the last 3 months.
Highest
Current 72,00 $
145,00 $ (+101,39%)
Average
128,67 $ (+78,71%)
Lowest
119,00 $ (+65,28%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boris Peaker
JonesTrading
Buy
Maintained
130,00 $
+80,6%
11/13/2026
Etzer Darout
Barclays
Buy
Maintained
145,00 $
+101,4%
11/13/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
125,00 $
+73,6%
11/13/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Upgraded
119,00 $
+65,3%
11/12/2026
Biren Amin
Piper Sandler
Buy
Maintained
123,00 $
+70,8%
09/28/2026
Maxwell Skor
Morgan Stanley
Buy
Reiterated
130,00 $
+80,6%
08/17/2026
Jeet Mukherjee
BTIG
Buy
Maintained
133,00 $
+84,7%
08/12/2026
Chad Messer
Lake Street
Buy
Maintained
103,00 $
+43,1%
06/30/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
115,00 $
+59,7%
05/15/2026
Soumit Roy
JonesTrading
Buy
Maintained
130,00 $
+80,6%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3,94 մլն
3,49 մլն
4,77 մլն
4,44 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,21 մլն
1,74 մլն
1,88 մլն
3,03 մլն
Operating expense
6,16 մլն
5,23 մլն
6,64 մլն
7,47 մլն
Total operating expenses
6,16 մլն
5,23 մլն
6,64 մլն
7,47 մլն
Operating income
-6,16 մլն
-5,23 մլն
-6,64 մլն
-7,47 մլն
Other non operating income
-1,00
-
32,16 հզր
-
EBT including unusual items
-5,20 մլն
-3,89 մլն
-5,31 մլն
-6,20 մլն
EBT excluding unusual items
-5,20 մլն
-3,89 մլն
-5,31 մլն
-6,20 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5,20 մլն
-3,89 մլն
-5,31 մլն
-6,20 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,61
-0,46
-0,62
-0,72
Interest and investment income
954,43 հզր
1,33 մլն
1,30 մլն
1,27 մլն
Interest expense
-
-
-
-
Net interest expenses
954,43 հզր
1,33 մլն
1,30 մլն
1,27 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps